Groowe Groowe / Newsroom / JNJ
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JNJ News

Johnson & Johnson

Company Culture Is Critical to Getting Business Value from AI

globenewswire.com
JNJ

New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause

businesswire.com
JNJ

New Senior Commercial Appointments at Neuromod

prnewswire.com
ALGN JNJ SONO

Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth

globenewswire.com
AMGN ARWR NVS ALNY SNY REGN ESPR JNJ AZN AMRN MRK LLY BMY ON NVO

Global Lightweight Materials Market Size, Share, Trends, and Forecast, 2026-2031 | EV and Aerospace Demand to Drive 8.72% CAGR, Reaching $354.33 Billion

globenewswire.com
AA AL F PCAR GD BA LMT RTX NOC HXL AVAV ADI TXN NVDA AMD INTC MSFT AMZN GOOGL IBM GE CAT DE MMM DD ALGN XRAY MRNA PFE JNJ BIIB GILD REGN VRTX AMGN BMY ABBV LLY TSLA NIO RIVN LCID GM STLA HMC TM VWAGY XPEV LI BYDDF CHPT PLUG FCEL SPWR ENPH SEDG NEE EXC BEP IRTC RCL CCL NCLH HAL SLB DV BNTX CRSP EDIT NTLA XOM CVX COP SBLK ZIM GNK TECK RIO BHP VALE NEM FCX AVNT NNDM SSYS CRON TLRY ACB CGC PYPL COIN BITF MARA RIOT CLSK PLTR SNOW CRWD PANW SMCI EXAS TDOC CI UNH CVS QCOM NXPI ON AEHR AMAT LRCX KLAC MU WDC

Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth

globenewswire.com
NVDA LLY CHAI TMO ABBV AMGN AZN BDX BMY CRL JNJ MRK NVS PFE REGN SNY VRTX

Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson

globenewswire.com
ABBV AZN PFE NVS JNJ AMGN BMY GILD BIIB TXMD UTHR

Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care

globenewswire.com
MRK BMY JNJ PDS BNTX INO IMPP CUE

CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J

globenewswire.com
BMY GILD JNJ

BioFuture 2026 Convenes Industry Leaders in New York City to Explore the Trends Reshaping Biopharma and Healthcare

prnewswire.com
JNJ REGN TMO